HeartSciences Says As Of April 30, 2024, Cash And Cash Equivalents Were ~$5.8M And Shareholders' Equity Was Approximately $7.3M
HeartSciences Says As Of April 30, 2024, Cash And Cash Equivalents Were ~$5.8M And Shareholders' Equity Was Approximately $7.3M
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.